Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CTRV

ContraVir Pharmaceuticals

$0.72

-0.0098 (-1.35%)

09:11
09/18/18
09/18
09:11
09/18/18
09:11
Hot Stocks
ContraVir Pharmaceuticals CRV431 study meets primary endpoints »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
CTRV

ContraVir Pharmaceuticals

$0.83

0.0595 (7.72%)

09:07
08/07/18
08/07
09:07
08/07/18
09:07
Hot Stocks
ContraVir Pharmaceuticals completes data analysis of second cohort »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$0.85

-0.1 (-10.53%)

16:44
07/24/18
07/24
16:44
07/24/18
16:44
Hot Stocks
Breaking Hot Stocks news story on ContraVir Pharmaceuticals »

Anson Funds Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$0.90

-0.0848 (-8.65%)

08:15
07/23/18
07/23
08:15
07/23/18
08:15
Hot Stocks
ContraVir Pharmaceuticals reports progress in Phase 1/2A trial of CRV 431 »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$1.21

(0.00%)

09:55
07/12/18
07/12
09:55
07/12/18
09:55
Conference/Events
PR Newswire to hold a virtual conference »

Virtual Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

CTRV

ContraVir Pharmaceuticals

$1.21

-0.04 (-3.20%)

08:17
07/12/18
07/12
08:17
07/12/18
08:17
Conference/Events
PR Newswire to hold a virtual conference »

Virtual Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

CTRV

ContraVir Pharmaceuticals

$1.16

-0.14 (-10.77%)

08:02
07/10/18
07/10
08:02
07/10/18
08:02
Upgrade
ContraVir Pharmaceuticals rating change at Maxim »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

CTRV

ContraVir Pharmaceuticals

$1.16

-0.14 (-10.77%)

07:37
07/10/18
07/10
07:37
07/10/18
07:37
Upgrade
ContraVir Pharmaceuticals rating change at Maxim »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

CTRV

ContraVir Pharmaceuticals

$1.35

-0.02 (-1.46%)

08:07
06/29/18
06/29
08:07
06/29/18
08:07
Hot Stocks
ContraVir announces $10.8M in expected gross proceeds from rights offering »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
CTRV

ContraVir Pharmaceuticals

$1.50

0.03 (2.04%)

16:25
06/25/18
06/25
16:25
06/25/18
16:25
Conference/Events
ContraVir Pharmaceuticals to hold a business news update conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.